152 related articles for article (PubMed ID: 29433089)
1. Proposal of potent inhibitors for vitamin-D receptor based on ab initio fragment molecular orbital calculations.
Takeda R; Kobayashi I; Suzuki R; Kawai K; Kittaka A; Takimoto-Kamimura M; Kurita N
J Mol Graph Model; 2018 Mar; 80():320-326. PubMed ID: 29433089
[TBL] [Abstract][Full Text] [Related]
2. Ligand chirality can affect histidine protonation of vitamin-D receptor: ab initio molecular orbital calculations in water.
Terauchi Y; Suzuki R; Takeda R; Kobayashi I; Kittaka A; Takimoto-Kamimura M; Kurita N
J Steroid Biochem Mol Biol; 2019 Feb; 186():89-95. PubMed ID: 30278216
[TBL] [Abstract][Full Text] [Related]
3. Specific interactions between vitamin-D receptor and its ligands: Ab initio molecular orbital calculations in water.
Takeda R; Kobayashi I; Shimamura K; Ishimura H; Kadoya R; Kawai K; Kittaka A; Takimoto-Kamimura M; Kurita N
J Steroid Biochem Mol Biol; 2017 Jul; 171():75-79. PubMed ID: 28242261
[TBL] [Abstract][Full Text] [Related]
4. Proposal of novel inhibitors for vitamin-D receptor: Molecular docking, molecular mechanics and ab initio molecular orbital simulations.
Nakamura S; Saito R; Yamamoto S; Terauchi Y; Kittaka A; Takimoto-Kamimura M; Kurita N
Biophys Chem; 2021 Mar; 270():106540. PubMed ID: 33418104
[TBL] [Abstract][Full Text] [Related]
5. 19F NMR study on the complex of fluorinated vitamin D derivatives with vitamin D receptor: elucidation of the conformation of vitamin D ligands accommodated in the receptor.
Morizono D
J Med Dent Sci; 2011 Dec; 58(4):103-12. PubMed ID: 23896933
[TBL] [Abstract][Full Text] [Related]
6. Interactions between 1alpha,25(OH)2D3 and residues in the ligand-binding pocket of the vitamin D receptor: a correlated fragment molecular orbital study.
Yamagishi K; Tokiwa H; Makishima M; Yamada S
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):63-7. PubMed ID: 20236613
[TBL] [Abstract][Full Text] [Related]
7. Ligand-dependent conformation change reflects steric structure and interactions of a vitamin D receptor/ligand complex: a fragment molecular orbital study.
Motoyoshi S; Yamagishi K; Yamada S; Tokiwa H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):56-9. PubMed ID: 20236615
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
[TBL] [Abstract][Full Text] [Related]
9. Atom-based and Pharmacophore-based 3D - QSAR Studies on Vitamin D Receptor (VDR).
Nagamani S; Kesavan C; Muthusamy K
Comb Chem High Throughput Screen; 2018; 21(5):329-343. PubMed ID: 29874993
[TBL] [Abstract][Full Text] [Related]
10. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
Mohr SC; Swamy N; Xu W; Ray R
Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
[TBL] [Abstract][Full Text] [Related]
11. The role of receptor topology in the vitamin D3 uptake and Ca(2+) response systems.
Morrill GA; Kostellow AB; Gupta RK
Biochem Biophys Res Commun; 2016 Sep; 477(4):834-840. PubMed ID: 27369077
[TBL] [Abstract][Full Text] [Related]
12. Specific interactions between 2-trans enoyl-acyl carrier protein reductase and its ligand: Protein-ligand docking and ab initio fragment molecular orbital calculations.
Phusi N; Sato R; Ezawa T; Tomioka S; Hanwarinroj C; Khamsri B; Kamsri P; Punkvang A; Pungpo P; Kurita N
J Mol Graph Model; 2019 May; 88():299-308. PubMed ID: 30826710
[TBL] [Abstract][Full Text] [Related]
13. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
15. Alternative binding sites at the vitamin D receptor and their ligands.
Mutchie TR; Yu OB; Di Milo ES; Arnold LA
Mol Cell Endocrinol; 2019 Apr; 485():1-8. PubMed ID: 30654005
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of vitamin D and VDR model.
Yamada S; Yamamoto K; Masuno H
Curr Pharm Des; 2000 May; 6(7):733-48. PubMed ID: 10828304
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model.
Yamada S; Yamamoto K; Masuno H; Choi M
Steroids; 2001; 66(3-5):177-87. PubMed ID: 11179725
[TBL] [Abstract][Full Text] [Related]
20. Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.
Yoshimoto N; Sakamaki Y; Haeta M; Kato A; Inaba Y; Itoh T; Nakabayashi M; Ito N; Yamamoto K
J Med Chem; 2012 May; 55(9):4373-81. PubMed ID: 22512505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
